HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Cristiana Ercolani Selected Research

NK Cell Lectin-Like Receptor Subfamily C

10/2011High expression of HLA-E in colorectal carcinoma is associated with a favorable prognosis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Cristiana Ercolani Research Topics

Disease

14Neoplasms (Cancer)
10/2020 - 04/2011
9Breast Neoplasms (Breast Cancer)
11/2021 - 04/2011
5Triple Negative Breast Neoplasms
10/2020 - 12/2015
5Neoplasm Metastasis (Metastasis)
10/2020 - 04/2011
3Melanoma (Melanoma, Malignant)
02/2020 - 11/2018
2Lung Neoplasms (Lung Cancer)
01/2022 - 06/2020
2Carcinoma (Carcinomatosis)
11/2014 - 10/2011
2Colorectal Neoplasms (Colorectal Cancer)
09/2013 - 03/2013
1Disease Progression
12/2020
1Anaplasia
01/2019
1Ataxia (Dyssynergia)
01/2019
1Ataxia Telangiectasia (Louis Bar Syndrome)
01/2019
1Lymphoma (Lymphomas)
05/2018
1Rare Diseases (Rare Disease)
08/2017
1Obesity
10/2016
1Male Breast Neoplasms (Male Breast Cancer)
10/2016
1Ductal Carcinoma
07/2016
1Residual Neoplasm
12/2015
1Genomic Instability
08/2014
1Necrosis
03/2013
1Fibrosis (Cirrhosis)
03/2013
1Fatty Liver
03/2013
1Pathologic Dilatation (Ectasia)
03/2013

Drug/Important Bio-Agent (IBA)

7Biomarkers (Surrogate Marker)IBA
01/2019 - 03/2013
6Hormones (Hormone)IBA
12/2020 - 04/2011
5Proteins (Proteins, Gene)FDA Link
06/2020 - 04/2011
3MicroRNAs (MicroRNA)IBA
02/2020 - 08/2014
2Pharmaceutical PreparationsIBA
10/2020 - 02/2020
2Phosphotransferases (Kinase)IBA
01/2019 - 01/2017
2Estrogen ReceptorsIBA
10/2017 - 08/2014
2SilverIBA
10/2017 - 04/2011
2ErbB Receptors (EGF Receptor)IBA
09/2013 - 04/2013
1RNA (Ribonucleic Acid)IBA
01/2022
1Ado-Trastuzumab EmtansineIBA
11/2021
1pyrvinium (Vankin)FDA Link
10/2020
1LipidsIBA
10/2020
1Conditioned Culture MediaIBA
06/2020
1Lysine AcetyltransferasesIBA
06/2020
1TubulinIBA
06/2020
1Histone Acetyltransferases (Histone Acetyltransferase)IBA
06/2020
1Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
06/2020
1EnzymesIBA
06/2020
1Angiogenesis InhibitorsIBA
06/2020
1CytokinesIBA
01/2020
1Interleukin-1 Receptors (Interleukin 1 Receptor)IBA
01/2020
1Interleukin 1 Receptor Antagonist Protein (Anakinra)FDA Link
01/2020
1Culture MediaIBA
01/2020
1Chemotactic FactorsIBA
01/2020
1Phenobarbital (Luminal)FDA Link
01/2019
1Histones (Histone)IBA
01/2019
1Semaphorins (Semaphorin)IBA
11/2018
1ChromatinIBA
11/2018
1Messenger RNA (mRNA)IBA
11/2018
1Proto-Oncogene Proteins c-mybIBA
11/2018
1Progesterone Receptors (Progesterone Receptor)IBA
10/2017
1A-Form DNA (A-DNA)IBA
02/2017
1N-acetyltalosaminuronic acid (NAT)IBA
01/2017
1DNA (Deoxyribonucleic Acid)IBA
12/2015
1Telomeric Repeat Binding Protein 1IBA
08/2014
1Lapatinib (GW572016)FDA Link
04/2013
1Trastuzumab (Herceptin)FDA Link
04/2013
1Capecitabine (Xeloda)FDA Link
04/2013
1Tyrosine Kinase InhibitorsIBA
04/2013
1CollagenIBA
03/2013
1Yttrium-90IBA
03/2013
1SurvivinIBA
03/2013
1Phospholipases (Phospholipase)IBA
03/2013
1Formaldehyde (Formol)FDA Link
10/2011
1HLA-A Antigens (HLA-A)IBA
10/2011
1NK Cell Lectin-Like Receptor Subfamily CIBA
10/2011
1ParaffinIBA
10/2011

Therapy/Procedure

9Therapeutics
01/2022 - 03/2013
3Neoadjuvant Therapy
01/2017 - 12/2015
2Ligation
10/2017 - 11/2014
2Drug Therapy (Chemotherapy)
02/2017 - 12/2015
1Microspheres (Microsphere)
03/2013
1Adjuvant Chemotherapy
03/2013